RxE2 Agrees to Acquire Habitu to Form the First AI Driven, Pharmacist-Led, Clinical Trial Platform
Fargo, ND, January 11, 2021 — RxE2, which is bringing the practice of pharmacy to clinical research, announced today it has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people’s habits and behaviors to create a KyP engine enabled by artificial intelligence, improving patient outcomes by providing real time analyses of a…